Similarly, mutations in the CASQ2 gene, present in 5% of all genetically-diagnosed CPVT patients, also lead to an abnormal Ca2+ leak through RyR2 by decreasing the expression of its encoded protein, calsequestrin 2 [147]. The gene discussed is CASQ2; the disease is catecholaminergic polymorphic ventricular tachycardia.